antibody

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

antibody
Dec 12, 2024, 06:56 | Science
Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites
Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites Malignant ascites is a…
Nov 30, 2024, 19:13 | Insight
Vivek Subbiah: ADC Target Expression and Interstitial Lung Disease in NSCLC
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Nov 24, 2024, 19:37 | Insight
Isabella Michelon: Meta-analysis of 2000+ patients with HER2-low and MBC
Isabella Michelon, 6th year medical student at the Catholic University of Pelotas, shared a recent…
Nov 24, 2024, 04:47 | Blog
Zanidatamab is approved by US FDA based off Herizon BTC01
Oncology Brothers shared a post on X: "Zanidatamab (bispecific antibody against Her2) now US FDA…
Jul 11, 2024, 06:26 | Insight
The Role of Antibody-Drug conjugates (ADCs) in Bladder Cancer
Bladder Cancer Advocacy Network shared on X: "Get practical guidance on using antibody–drug conjugates in…
Oct 29, 2023, 16:16 | Dialogues
5 min OncoDaily Updates with Chandler Park: Dr. Grivas on the 1st clinical study of 2 different antibody drug conjugates
[embed]https://www.youtube.com/watch?v=kc06AUL3gCA[/embed]
Jun 18, 2023, 16:32 | Drugs
FDA approved our new bispecific antibody for treating people with relapsed or refractory Diffuse Large B-cell Lymphoma
In a post by Alexander Hardy on Linkedin, it says, "I’m excited to share that…
May 14, 2023, 09:34 | Drugs
Amivantamab Shows Efficacy in Advanced NSCLC With EGFR Exon 20 Insertions - The ASCO Post
Quoting from ASCO Post, "Amivantamab-vmjw, an EGFR and MET bispecific monoclonal antibody, has demonstrated encouraging…
All: 8 Posts: 1 - 100
Special Coverage